How to store BPC-157: does it need a fridge, and how long does it last once mixed?

Does BPC-157 need to be refrigerated?

No official answer exists, because BPC-157 has no approved label in any country. FDA says it lacks enough information to judge its safety and flags impurity concerns. The defensible default is the refrigerated standard an approved peptide injection follows: 2-8C (36-46F), protected from light, and never frozen.

Most storage questions have a boring answer: read the label. BPC-157 is the exception, because there is no label to read. FDA's own page on compounding risks says that compounded drugs containing BPC-157 may have complexities with regard to peptide-related impurities and active pharmaceutical ingredient (API) characterization (API meaning the drug substance itself), and that the agency lacks sufficient information to know whether the drug would cause harm when given to people [1]. Whether BPC-157 is legal to sell is a separate question, covered in is BPC-157 legal in the US.

A storage section is part of an approved label. It is written from stability studies a manufacturer runs on one specific formulation and submits for review. Nobody has done that for BPC-157, so every storage figure you read online, including the ones below, is borrowed from somewhere else.

The sensible place to borrow from is an approved peptide injection. Tirzepatide, the peptide in Lilly's Zepbound and Mounjaro, should be stored in the refrigerator, between 36°F and 46°F (2°C to 8°C), and kept in its original carton to protect it from light [7]. That rule was earned by a different molecule in a different formulation, so it is a standard of care to copy, not a promise about BPC-157.

Where "BPC-157 is stable" comes from

The claim that BPC-157 is unusually stable comes from the Zagreb group that first described it, and refers to surviving human gastric juice for more than 24 hours. That is a statement about digestion, not about a vial on a shelf. No published study we could find gives BPC-157 a storage shelf life in any form.

Storage guides for BPC-157 often lean on one word: stable. The word is in the peptide's full name as its developers use it, stable gastric pentadecapeptide BPC 157 (pentadecapeptide meaning a chain of 15 amino acids). It traces to the work of Sikiric and colleagues, who isolated the peptide from human gastric juice in 1993 [2]. A 2026 review from that group, at the University of Zagreb, describes BPC-157 as native and stable in human gastric juice (more than 24 h) [3].

That is a claim about one environment: stomach acid and digestive enzymes. It says nothing about how long the peptide stays intact dissolved in water in a home refrigerator, or as a powder in a warm mailbox. A 2022 pharmacokinetics paper repeats a broader version in its introduction, that BPC-157 can be stored at room temperature and resists hydrolysis, enzyme digestion and gastric juice, citing the Zagreb group rather than any storage experiment of its own [2]. It does not say in what form, for how long, or at what purity.

The same paper shows how short-lived the peptide is once it is in the body. Given intravenously, BPC-157 had an average elimination half-life (the time for its blood level to halve) of 15.2 min in rats and 5.27 min in dogs, and the intact peptide could not be detected 4 h after dosing in rats [2]. None of that is a shelf life either. It is a reminder that "stable" in one setting does not carry over to another, which is the whole problem with borrowing numbers. Why the route matters for BPC-157 at all is covered in BPC-157 oral vs injection.

Powder and mixed are two different clocks

Freeze-dried BPC-157 powder and a mixed vial are different storage problems. Water starts the chemistry that breaks peptides down, and adding it is also when contamination can get in. That is why the dry powder is the more stable form, and why the clock that matters starts on the day you mix.

BPC-157 sold as a research peptide usually arrives as a lyophilized powder (freeze-dried, with the water removed) in a sealed vial, and the buyer adds liquid to it. That step, called reconstitution, is where the storage problem changes. A formulation review of therapeutic peptides lists the reactions that degrade peptides in water, including oxidation, hydrolysis (water breaking the bonds that hold the chain together) and deamidation (a chemical change to certain amino acid side chains), and physical problems such as aggregation (molecules clumping together) and precipitation [4].

The same review calls lyophilization with suitable stabilizers an ideal approach to keeping peptides intact, notes that reconstitution itself poses a risk of contamination, and says most peptide drugs need cold storage and transport, the cold chain, because of their instability [4]. It also explains why the dark matters: oxidation can be induced by light exposure, and aqueous injectable peptides are often stored at low temperatures and protected from light to minimize degradation [4].

So the dry powder is the safer form to keep, and adding water is what starts the clock. What no source gives is the length of either clock for BPC-157. The expiry date printed on a research vial is set by whoever filled it, under conditions you cannot check.

How long does BPC-157 last after reconstitution?

No study has measured it. The 28 days often quoted is the CDC rule for opened, manufacturer-labeled multi-dose vials, which typically contain a preservative. It caps contamination risk, not potency. A vial mixed with preservative-free sterile water gets no multi-week window at all and is best treated as single use.

Online guides give different answers, and the ones we found cite no measurement on BPC-157. The number with an actual source behind it is 28 days, and it comes from CDC guidance on multi-dose vials, not from any BPC-157 study [6]. CDC injection-safety guidance says that once a multi-dose vial is opened (for example, punctured by a needle) it should be dated and discarded within 28 days unless the manufacturer states another date for that opened vial [6]. CDC describes multi-dose vials as typically containing an antimicrobial preservative to help limit the growth of bacteria, and adds that the preservative does not provide complete protection against bacterial contamination [6].

Read that carefully and three limits fall out. The 28 days is a ceiling, not a target. It is about contamination, not about whether the peptide is still chemically intact. And it assumes a preservative. Bacteriostatic water carries one, 0.9% or 1.1% benzyl alcohol, and comes in a multiple-dose container meant for repeated withdrawals [5]. Plain sterile water does not. CDC says single-dose vials typically lack an antimicrobial preservative and that leftover contents should not be stored for later use [6], so a vial mixed with sterile water is best treated as a single-use preparation.

The diluent's own label is stricter than the guides. The DailyMed label for bacteriostatic water for injection says "Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute" [5]. For BPC-157 there is no manufacturer direction to follow, so every multi-week plan for a mixed vial is a judgment call. Our general guide to how long reconstituted peptides last makes the same distinction for every peptide.

Left out of the fridge, frozen or cloudy

There are no BPC-157 data on temperature excursions, so nobody can say how long a vial survives on the counter. Freezing can make peptides clump, so a vial that froze is suspect. A cloudy, discolored or particle-filled solution should be discarded. A clear one is not proof of potency.

The most common version of this question is the morning after: the vial sat out overnight, or the fridge failed. For an approved drug, the label answers it with a measured allowance. For BPC-157, nothing does, and the generous room-temperature windows on approved drugs were measured for those products only.

Freezing deserves its own warning, because it is easy to do by accident at the back of a home fridge. The formulation review lists freezing, heating, or agitation among the stress conditions that may induce aggregation [4]. Shaking a vial hard to dissolve the powder is the agitation half of the same warning.

What approved labels do give you is a set of visual discard rules that make sense for any clear injectable solution. Zepbound's label says its solution should appear clear and colorless to slightly yellow, and not to use it if particulate matter or discoloration is seen [10], and the bacteriostatic water label says not to use the diluent itself unless the solution is clear and the seal intact [5]. The rule that matters most runs the other way: oxidation and hydrolysis are chemical changes [4], and confirming whether they happened takes a laboratory, not a look at the vial. A cloudy vial is proof of a problem; a clear one is not proof of potency.

Whose expiry date is on the vial?

The date on a research vial of BPC-157 is the seller's claim, backed by no reviewed stability data. FDA flags impurity and characterization problems with the substance, and a 2026 orthopaedic review lists concerns about the identity, purity, concentration and sterility of commercial products. Storage cannot fix a vial that started wrong.

For approved drugs, two parties can set a storage date: the manufacturer, through the label, and a licensed pharmacy that compounds the drug and assigns it a beyond-use date. CDC points to USP General Chapter 797 as the sterile compounding standard, and that chapter counts reconstituting a drug as sterile compounding [6]. BPC-157 bought online has neither. If a licensed pharmacy ever dispenses it to you, the beyond-use date on that label is the one to follow, because it is the only date tied to a compounding standard. FDA's concerns about the substance itself, peptide-related impurities and the difficulty of characterizing the drug substance [1], apply before any question of storage.

Clinicians who see patients using it say the same. A 2026 review in the Journal of the American Academy of Orthopaedic Surgeons notes that commercial products raise concerns about identity, purity, concentration, sterility, and manufacturing consistency, and that validated dosing, pharmacokinetic and long-term safety data are lacking [8]. A 2025 commentary in Arthroscopy describes BPC-157 as unregulated yet readily available for purchase over the internet [9].

That changes what storage can and cannot do. Good storage slows the loss of whatever was in the vial on the day it arrived. It cannot tell you what that was. How to read a seller's certificate of analysis, and what one does and does not prove, is the subject of our guide to vetting research peptides. To understand the peptide itself before deciding anything, our BPC-157 course covers the chemistry, the animal evidence and the safety record.

A storage routine built on what is known

Keep sealed powder refrigerated and dark, mix only when needed, label each vial with the date and the diluent, and treat 28 days as the outside limit for a bacteriostatic-water vial. Treat a sterile-water vial as single use. Discard anything frozen, cloudy, discolored or of unknown temperature history.

Put together, the documents support a short routine, and each step traces to something above. Keep sealed powder in a refrigerator, between 36°F and 46°F (2°C to 8°C), in its box or another dark container, copying the storage rule for an approved peptide injection, tirzepatide [7]. That is a borrowed rule, not a tested one for BPC-157 powder. Do not freeze it, since freezing is one of the stresses that can make peptides clump [4]. Mix only when you need to, since the dry form is the stable one and light and water both drive degradation [4]. Swirl gently rather than shake. Label the vial the day it is mixed with the date and the diluent used.

Then apply the strictest rule that fits. With bacteriostatic water, treat 28 days from first puncture as the outside ceiling, the figure CDC sets for discarding opened multi-dose vials [6]. It is a contamination rule, not a measure of potency. With sterile water, which has no preservative, treat the contents as a single-use preparation. And whatever the calendar says, discard a vial that froze, clouded, changed color or grew particles. Discoloration and particles are the discard signs an approved label names [10], cloudiness means the solution is no longer clear, and freezing can cause clumping [4].

If the vial has to travel, the cold chain becomes the hard part. Our guide to flying with peptides covers airport screening, insulated cases and customs, and the peptide reconstitution guide covers sterile technique and the arithmetic of mixing, without telling anyone what to inject.